Digital Genome Market : 2018 Prominent Players | Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference

Digital Genome Market to exceed USD 45 billion by 2024 as per a new research report.

Growing demand for personalized medicine and rising prevalence of chronic disorders will drive industry growth over the forecast timeframe. Digital genome becoming an emerging market owing to huge investment and funding received from government and private research organizations. Thus, fueling demand for digital genome.

Successful completion of human genome project has stimulated growth of forensics, human evolution, microbial genomics and molecular medicine fields. Free availability of complete human genome sequence on internet will fuel digital genome market share growth over the forecast period. Advancements in biotechnology such as shift from traditional plant and animal sciences to molecular systematics should drive market growth over the coming years.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1219

Reduction in cost and time required for DNA sequencing due to advancements in DNA sequencing techniques and genomics will fuel digital genome market growth. However, dearth of skilled personnel along with unclear return on investment will restrain market growth over the forecast period.

Sequencing and analyzer instruments market held largest revenue share in 2016 due to advancements in gene sequencing techniques leading to create demand for DNA sequencing. Rising adoption of precision medicine designed to suit patient’s genetic makeup has further added to growth of this segment.

Research and development segment dominated the revenue share in 2016. Increasing investments and funding received from government and research institutes for molecular genomics application and DNA sequencing will drive growth of this segment during the forecast period. Growing research activities for reducing cost associated with DNA sequencing, development of computer tools able to map gene sequence and sequence-tagged site mapping should stimulate research and development growth.

Increasing demand for personalized medicines has stimulated biopharmaceutical companies for using genomics to discover mutant genes responsible for certain disorders as well as increasing precision in treatment has led biopharmaceutical segment to contribute largest revenue in 2016 with considerable growth during forecast years.
U.S. held largest market revenue share in 2016 owing to favorable government initiatives such as precision medicine initiative and rising incidences of chronic diseases in the U.S. Growing application of genomics by hospitals in the country for cancer treatment and successful completion of human genome project will further foster industry growth.

Increasing number of people suffering from genetic disorders, rising investment for growth of digital genomics and favorable government initiatives should fuel Indian digital genome market over the forecast period.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1219

Few notable industry players are Foundation Medicine, Macrogen, Quest Diagnostics, Rosetta Genomics, Cancer Genetics, CombiMatrix Corporation, Genomic Health, NanoString Technologies, Regeneron Pharmaceuticals and Sequenom.

Industry players are consolidating their market position by increasing their focus on research activities to develop new cost-effective DNA sequencing technologies. Partnership, strategic collaboration are key strategies followed by market players.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

This release was published on openPR.